Compass Therapeutics Announces Publication of Phase 2/3 COMPANION-002 Results for Tovecimig in the Journal of Clinical Oncology and Oral Presentation at ESMO 2026

As published in the Journal of Clinical Oncology (JCO) and presented at ESMO, COMPANION-002 met its primary endpoint of ORR and key secondary ...
PR Newswire

Lunit and Summit Therapeutics Announce Agreement to Apply AI-powered SCOPE IO Platform for Tumor Microenvironment Analysis in Immuno-Oncology Development

Lunit Inc. (KRX: 328130) and Summit Therapeutics Inc. (NASDAQ: SMMT) today announced a research agreement to evaluate the use ...
BIOENGINEER

Flame-made nanosilver woven into chitosan fibers fights resistant wound bacteria

Researchers have combined flame spray pyrolysis and electrospinning to create chitosan-containing nanofiber dressings that release sustained silver ions from embedded sub-10-nm nanoparticles, showing ...
oncodaily

CROWN: ctDNA Analysis Identifies Genomic Features Linked to Early Lorlatinib Progression in ALK+ NSCLC

CROWN ctDNA data link early lorlatinib progression to genomic complexity, TP53 and bypass pathways rather than new ALK ...
Bastille Post

HKAGE Showcases Gifted Students' Learning Journeys at InnoCarnival 2026

The Hong Kong Academy for Gifted Education (HKAGE) has been invited to participate in InnoCarnival 2026, organised by the ...
Bastille Post

DCK Showcases Battery-Powered Lawn and Garden Equipment at Equip Exposition 2026

The 20V range offered cordless options for routine garden tasks, while the 40V series further expanded DCK's garden tool ...

Summit Therapeutics and Lunit Announce Agreement to Apply AI-powered SCOPE IO Platform for Tumor Microenvironment Analysis in Immuno-Oncology Development

Research Will Use Lunit’s AI-powered Pathology Platform to Analyze H&E Whole-Slide Images and Generate Scalable Insights into ...